Cash figures as of 2025-12-31. Database snapshot: 2026-09-21.
Price history
Loading NRSN daily closes…
Loading price history…
Pipeline assets
PrimeC
Stage not disclosed · Active
Status note Named as the company's lead product candidate; company is dependent on its success, including obtaining regulatory approval to market PrimeC in the United States. The 20-F excerpts contain no indication, stage, modality, target, or partnership for PrimeC, and no preclinical candidates are named.
Per-asset detail extracted from the 20-F filed 2026-05-15. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.
No lead program on file for this company.
No active ClinicalTrials.gov trials matched to this company as sponsor or collaborator.
No specialist-fund holders in 13F data for this company.
Get the weekly biotech catalyst rundown. Cash runways, financings, and trial readouts for all 714 stocks.